Abstract:Background: Alongside microbiota development, the evolution of the resistome is crucial in understanding the early-life acquisition and persistence of Antibiotic Resistance Genes (ARGs). Therefore, the aim of this study is to provide a comprehensive view of the evolution and dynamics of the neonatal resistome from 7 days to 4 months of age using a high-throughput qPCR platform. Methods: In the initial phase, a massive screening of 384 ARGs using a high-throughput qPCR in pooled healthy mother-infant pairs feces from the MAMI cohort was carried out to identify the most abundant and prevalent ARGs in infants and in mothers. This pre-analysis allowed for later targeted profiling in a large number of infants in a longitudinal manner during the first 4 months of life. 16S rRNA V3-V4 amplicon sequencing was performed to asses microbial composition longitudinally. Potential factors influencing the microbiota and ARGs in this period were also considered, such as mode of birth and breastfeeding type. Results: Following the massive screening, the top 45 abundant ARGs and mobile genetic elements were identified and studied in 72 infants during their first months of life (7 days, 1, 2, and 4 months). These genes were associated with resistance to aminoglycosides, beta-lactams and tetracyclines, among others, as well as integrons, and other mobile genetic elements. Changes in both ARG composition and quantity were observed during the first 4 months of life: most ARGs abundance increased over time, but mobile genetic elements decreased significantly. Further exploration of modulating factors highlighted the effect on ARG composition of specific microbial genus, and the impact of mode of birth at 7 days and 4 months. The influence of infant formula feeding was observed at 4-month-old infants, who exhibited a distinctive resistome composition. Conclusions: This study illustrates the ARG evolution and dynamics in the infant gut by use of a targeted, high-throughput, quantitative PCR-based method. An increase in antibiotic resistance over the first months of life were observed with a fundamental role of delivery mode in shaping resistance profiles. Further, we highlighted the influence of feeding methods on the resistome development. These findings offer pivotal insights into dynamics of and factors influencing early-life resistome, with potential avenues for intervention strategies.

CRISPR dynamics during the interaction between bacteria and phage in the first year of life

Dynamics of CRISPR-mediated virus-host interactions in the human gut microbiome

Infant gut DNA bacteriophage strain persistence during the first 3 years of life

Escherichia coli CRISPR arrays from early life fecal samples preferentially target prophages

Roles of bacteriophages, plasmids and CRISPR immunity in microbial community dynamics revealed using time-series integrated meta-omics

Antibiotic resistance gene dynamics in the commensal infant gut microbiome over the first year of life

CRISPR adaptation in can be driven by phage environmental DNA

CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures

CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea

Candidate Phyla Radiation Roizmanbacteria From Hot Springs Have Novel and Unexpectedly Abundant CRISPR-Cas Systems

Real-time capture of horizontal gene transfers from gut microbiota by engineered CRISPR-Cas acquisition

Advances in CRISPR-Cas systems for gut microbiome

Unravelling the evolutionary dynamics of antibiotic resistance genes in the infant gut microbiota during the first four months of life

Insights into the ecology of the infant gut plasmidome

Editing the microbiome the CRISPR way

How the other half lives: CRISPR-Cas's influence on bacteriophages

CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool

Molecular mechanisms of CRISPR-mediated microbial immunity

Physical Model of the Immune Response of Bacteria Against Bacteriophage Through the Adaptive CRISPR-Cas Immune System

CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage